BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16789752)

  • 1. Activation of murine RNase L by isopolar 2'-phosphonate analogues of 2',5' oligoadenylates.
    Pav O; Protivinska E; Pressova M; Collinsova M; Jiracek J; Snasel J; Masojidkova M; Budesinsky M; Rosenberg I
    J Med Chem; 2006 Jun; 49(13):3955-62. PubMed ID: 16789752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human RNase L by 2'- and 5'-O-methylphosphonate-modified oligoadenylates.
    Páv O; Panova N; Snášel J; Zborníková E; Rosenberg I
    Bioorg Med Chem Lett; 2012 Jan; 22(1):181-5. PubMed ID: 22169265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates.
    Sawai H; Hirano A; Mori H; Shinozuka K; Dong B; Silverman RH
    J Med Chem; 2003 Nov; 46(23):4926-32. PubMed ID: 14584943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
    Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
    Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization aiming at phosphonate analogues of oligoadenylates.
    Pressová M; Liboska R; Budesínský M; Králíková S; Kavenová I; Rosenberg I
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1049-52. PubMed ID: 14565341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2',5'-oligoadenylate analogs possessing a linker moiety in the place of the second adenosine and their ability to activate human RNase L.
    Nakamura T; Ito Y; Mochizuki M; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2007; (51):449-50. PubMed ID: 18029780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
    Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
    Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
    Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical synthesis and biological activities of partially inosine-substituted 2',5'-oligoadenylates: functional discrimination of three adenine amino groups on 2-5A for the binding to and activation of 2-5A-dependent endonuclease.
    Imai J; Lesiak K; Torrence PF
    Nucleic Acids Symp Ser; 1984; (15):81-4. PubMed ID: 6522297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
    Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
    ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
    [No Abstract]   [Full Text] [Related]  

  • 13. Oligonucleotide structural features involved in binding to and activation of the 2-5A-dependent endoribonuclease of L cells.
    Imai J; Lesiak K; Johnston MI; Torrence PF
    Nucleic Acids Symp Ser; 1982; (11):97-100. PubMed ID: 7183979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural changes of human RNase L upon homodimerization investigated by Raman spectroscopy.
    Kříž M; Snášel J; Kopecký V; Páv O; Rosenberg I; Stěpánek J
    Biochim Biophys Acta; 2012 Sep; 1824(9):1039-44. PubMed ID: 22691533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
    Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
    Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.
    Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotides with isopolar phosphonate internucleotide linkage: a new perspective for antisense compounds?
    Rejman D; Snásel J; Liboska R; Tocík Z; Paces O; Králíková S; Rinnová M; Kois P; Rosenberg I
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):819-23. PubMed ID: 11563123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respective role of each of the purine N7 nitrogens of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine in binding to and activation of the RNase L of mouse cells.
    Jamoulle JC; Lesiak K; Torrence PF
    Biochemistry; 1987 Jan; 26(2):376-83. PubMed ID: 3030408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of oligoribonucleotides with phosphonate-modified linkages.
    Páv O; Košiová I; Barvík I; Pohl R; Buděšínský M; Rosenberg I
    Org Biomol Chem; 2011 Sep; 9(17):6120-6. PubMed ID: 21769370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of uronic acid analogues of 2-5A[5'-O-triphosphoryladenylyl(2----5')adenylyl-(2'----5')adenosine].
    Kinjo JE; Pabuccuoglu A; Alster DK; Lesiak K; Torrence PF
    Drug Des Discov; 1992 Feb; 8(3):241-54. PubMed ID: 1525304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.